Literature DB >> 48743

Letter: Clofibrate and gallstones.

J Cooper, H Geizerova, M F Oliver.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 48743     DOI: 10.1016/s0140-6736(75)91845-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Gemfibrozil treatment: a comparison with clofibrate.

Authors:  A N Howard; P Ghosh
Journal:  Proc R Soc Med       Date:  1976

2.  Primary and secondary prevention trials in coronary heart disease.

Authors:  A G Shaper
Journal:  Postgrad Med J       Date:  1976-07       Impact factor: 2.401

3.  Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil.

Authors:  I J A M Jonkers; A H M Smelt; M Ledeboer; M E Hollum; I Biemond; F Kuipers; F Stellaard; R Boverhof; A E Meinders; C H B W Lamers; A A M Masclee
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

4.  Primary prevention of ischaemic heart disease: WHO coordinated cooperative trial. A summary report.

Authors: 
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

5.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.

Authors: 
Journal:  Br Heart J       Date:  1978-10

Review 6.  Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia.

Authors:  J A Balfour; D McTavish; R C Heel
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

Review 7.  Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia.

Authors:  P A Todd; A Ward
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

8.  [Relation between serum lipoprotein metabolism and biliary lipid metabolism].

Authors:  O Leiss; K von Bergmann
Journal:  Klin Wochenschr       Date:  1983-06-15

Review 9.  Drug-induced gallbladder disease. Incidence, aetiology and management.

Authors:  P P Michielsen; H Fierens; Y M Van Maercke
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

Review 10.  Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.

Authors:  J H Iser; A Sali
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.